Literature DB >> 2934800

The effects of topical treatment with steroids or dithranol on epidermal T lymphocytes and dendritic cells in psoriasis.

B S Baker, A F Swain, C E Griffiths, J N Leonard, L Fry, H Valdimarsson.   

Abstract

We describe the effects of treatment with topical steroids or dithranol on T and dendritic cells in the skin of patients with chronic plaque psoriasis. Resolution of lesions by both types of topical treatments was accompanied by a marked decrease in epidermal T cells. In steroid treated lesions there was also a reduction in DR+ dendritic cells to normal numbers during treatment and the rate of disappearance of both cell types correlated with the rate of resolution. However, a significant reduction of dendritic cells was not usually observed until after the T cells had almost disappeared from the epidermis and substantial healing of lesions had taken place. Dendritic cells in steroid-treated uninvolved skin had decreased to a lower level than in normal skin. In contrast, dithranol did not affect dendritic cells, either in lesional or in unaffected psoriatic epidermis. The decrease in dermal T cells observed with both treatments was more marked in steroid-treated lesions and correlated with resolution. However, blood T cells were unaffected by both treatments. The findings provide further support for the role of T cells in the pathogenesis of psoriasis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2934800     DOI: 10.1111/j.1365-3083.1985.tb01905.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  7 in total

1.  Psoriasis.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1986-07-26

Review 2.  Cytokine-based therapy in psoriasis.

Authors:  Anupam Mitra; Robyn S Fallen; Hermenio Cavalcante Lima
Journal:  Clin Rev Allergy Immunol       Date:  2013-04       Impact factor: 8.667

3.  Histopathological and immunohistochemical changes in psoriatic skin during peptide T treatment.

Authors:  T Talme; B L Rozell; K G Sundqvist; L Wetterberg; J A Marcusson
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

4.  Lymphocytes and macrophages of the epidermis and dermis in lesional psoriatic skin, but not epidermal Langerhans cells, are depleted by treatment with cyclosporin A.

Authors:  A K Gupta; O Baadsgaard; C N Ellis; J J Voorhees; K D Cooper
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

5.  Is an epitope on keratin 17 a major target for autoreactive T lymphocytes in psoriasis?

Authors:  A S Gudmundsdottir; H Sigmundsdottir; B Sigurgeirsson; M F Good; H Valdimarsson; I Jonsdottir
Journal:  Clin Exp Immunol       Date:  1999-09       Impact factor: 4.330

6.  Myeloperoxidase Inhibition Ameliorates Plaque Psoriasis in Mice.

Authors:  Savannah D Neu; Anna Strzepa; Dustin Martin; Mary G Sorci-Thomas; Kirkwood A Pritchard; Bonnie N Dittel
Journal:  Antioxidants (Basel)       Date:  2021-08-25

7.  Targeting IL-23: insights into the pathogenesis and the treatment of psoriasis.

Authors:  Hermenio Cavalcante Lima; Alexandra Boer Kimball
Journal:  Indian J Dermatol       Date:  2010 Apr-Jun       Impact factor: 1.494

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.